Lung Cancer Trial, Not Yet Recruiting NCT07588347 Sponsor: Feifei Huang Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT07588347
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

For patients:

  • A doctor has confirmed a diagnosis of primary lung cancer through laboratory or tissue testing.
  • Male patients must be 22 years of age or older; female patients must be 20 years of age or older.
  • The patient has already had lung cancer surgery and is scheduled to start their first round of radiation therapy and/or chemotherapy.
  • The patient scores 13 or higher on a specific questionnaire (called the FCRI-SF) that measures moderate-to-severe fear of cancer coming back.
  • The patient's general physical functioning meets a certain level, rated 2 or below on a standard medical scale called the ECOG scale (confirm with trial site).
  • The patient knows about their diagnosis and is willing to take part voluntarily.
  • The patient has normal cognitive (thinking and memory) function, as measured by a standard test called the MoCA (score of 26 or above), and is able and willing to communicate clearly.

For spouse caregivers:

  • The spouse has been identified by the patient as their main caregiver, providing more than half of the care over the past two weeks.
  • The caregiver is legally married to the patient.
  • Male caregivers must be 22 years of age or older; female caregivers must be 20 years of age or older.
  • The caregiver has normal cognitive function (MoCA score of 26 or above), has no diagnosed mental health conditions, and is able and willing to communicate clearly.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

For patients:

  • The patient has a diagnosed mental health condition or is currently receiving psychiatric treatment.
  • The patient has a personality disorder, intellectual disability, memory disorder, brain injury, or neurological disease.
  • The patient has cancer in another organ at the same time.
  • The patient has serious complications, such as chest pain or difficulty breathing caused by the tumour spreading to surrounding areas.
  • The patient's spouse caregiver is unwilling to take part in the trial.
  • The patient has a history of fractures or surgery to the upper limbs that has affected the use of their hands.
  • The patient is already taking part in another similar psychological support program.

For spouse caregivers:

  • The caregiver has a serious health condition of their own, such as respiratory failure, another cancer, or another critical illness.
  • The patient linked to the caregiver is unwilling to take part in the trial.
  • The caregiver is already taking part in another research study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Feifei Huang, Ph. D, Fujian Medical University

Phone: +86 13763869099

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Feifei Huang
Registry
ClinicalTrials.gov
Start date
15 May 2026
Est. completion
30 June 2027

Primary endpoints

Change from baseline in fear of cancer recurrence severity of lung cancer patients-The Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF); Change from baseline in fear of cancer recurrence severity of spouse caregivers-Fear of Cancer Recurrence Inventory Short Form-Caregiver Version (FCRI-SF-C)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov